Harleysville, PA, United States of America

David B Whitman

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 114(Granted Patents)


Location History:

  • Harleysville, PA (US) (2014)
  • Phoenixville, PA (US) (1993 - 2024)

Company Filing History:


Years Active: 1993-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovations of David B Whitman

Introduction

David B Whitman is a notable inventor based in Harleysville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of spiropiperidine derivatives. With a total of 9 patents to his name, Whitman has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Whitman's latest patents focus on spiropiperidine compounds that have shown activity as fatty acid synthase inhibitors. These compounds are described in detail according to Formula I, and they are part of pharmaceutical compositions aimed at treating diseases mediated by fatty acid synthase. The patents also outline methods for synthesizing these compounds, including the spiropiperidine derivatives and synthetic intermediates that are useful in their production.

Career Highlights

Throughout his career, David B Whitman has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Whitman has collaborated with esteemed colleagues such as Christopher D Cox and Mark E Duggan. These partnerships have further enriched his work and have led to innovative breakthroughs in his field.

Conclusion

David B Whitman is a distinguished inventor whose work in spiropiperidine derivatives has the potential to impact the treatment of various diseases. His contributions to the pharmaceutical industry reflect a dedication to innovation and excellence.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…